The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators. October 1, 2018 | By Medibio Team Sydney, Australia and Minneapolis, MN USA – Oct. 01, 2018: Medibio Limited [...]
Medibio Announces Executive Leadership Changes Sydney, Australia and Minneapolis, MN USA – 21 September 2018: The Board of Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), today announced several changes to the Company’s executive leadership team. Medibio is pleased [...]
Medibio releases transcript from September 11, 2018 call responding to investors' questions about recently released clinical study results. View Transcript
Medibio Clinical Study Shows Over 20% Improvement to Current Diagnostic Standard September 6, 2018 | By Medibio Team Highlights: - Global 230 patient (8 sites) study confirms Medibio’s Depression Diagnostic Aide (DX04) - With 70% accuracy, 70% sensitivity [...]
September 5, 2018 | By Medibio Team Medibio today announced that Lindsey Hagan has joined the company as VP of Integrated Health Systems. As VP of the Integrated Health Systems business unit, Hagan will partner with the company’s technology [...]
August 28, 2018 | By Medibio Team From TECHdotMN: Jeremy Schroetter is the CTO of Medibio, makers of a cloud-based platform for managing mental health. How long have you been working in tech for and what is your technical background? Writing [...]
Medibio Submits FDA De Novo Application Sydney, Australia and Minneapolis, MN USA – 16 July 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today announced the U.S. Food and Drug Administration (FDA) [...]
Peer-reviewed Neurology Publication on Medibio Science Medibio announces that a clinical article by Defillo et al. titled “Physiological Differences between Mood Disorder Phenotypes Based on Heart Rate Variability” has been published in EC Neurology, an internationally peer-reviewed journal. [...]
Sydney, Australia and Minneapolis, MN USA – 19 June 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announced today it has received confirmation that the Company’s Depression Diagnostic Aide (DDA) and Mental Health Monitoring [...]
Medibio Broadens Opportunities with Compatibility to Fitbit Wearable Devices for Mental Health Measurement Fitbit joins Apple Watch, Garmin and others allowing users to help process biometric data for an objective view of mental health Sydney, Australia, and Minneapolis, [...]
